Specialization

Cancer Biomarkers & Molecular Epidemiology, Respiratory Genetics

Email

siddharthsharma.phd@thapar.edu; Date of Joining: 01-07-2011

 

Specialization

Cancer Genetics | Respiratory Genetics | Molecular Epidemiology

Email

siddharthsharma.phd@thapar.edu; Date of Joining: 01-07-2011

 

Professional Summary:

Siddharth Sharma, currently a Professor in the Department of Biotechnology, Thapar Institute of Engineering & Technology, Patiala, India, received an M.S. degree in life sciences from Pondicherry Central University, India, 1998 and a PhD in biotechnology from Panjab University, India, in 2004. He joined NIPER, Mohali, as a Research Associate, where he worked on the ageing mechanism. He was a Post-Doctoral Research Fellow with the Department of Molecular Biology at the University of Cape Town, South Africa, where he worked in proteomics. He then joined the Department of Pathology, Miller School of Medicine, University of Miami, USA, as a Post-Doctoral Fellow, working on stem cells. He has been with the Department of Biotechnology, Thapar University, Patiala, India, since 2011 as an Assistant Professor. His research interests include the role of single nucleotide polymorphisms as biomarkers for cancer diagnosis and prognosis. His current research is focused on the Genomic profiling of lung cancer, primarily related to risk assessment, biomarker expression about clinical outcomes, and toxicogenomics in lung cancer. Dr. Sharma is also pursuing his research in COPD to identify single nucleotide polymorphic variants in different signaling pathway genes and their association with COPD. Dr Sharma is also working on the molecular predictors of drug-induced liver injury in patients on anti-tubercular drugs. He has authored over 85 research papers in SCI journals of international repute. He has guided 9 Ph.D students, 28 MSc students, 14 M.Tech students, and 4 MD students in their research. ICMR and CSIR have funded Dr. Siddharth for his research projects. He is currently teaching subjects to both undergraduate and postgraduate students, like Stem cell technology, Animal biotechnology, cancer biology, etc

 

My current research is focused on Genomic profiling of COPD & Lung cancer

a Risk assessment & Polymorphism relation to cancer susceptibility and clinical outcomes.

b Biomarker expression related, especially clinical outcomes

c  Inflammation and chronic disease

 

PROFESSIONAL IDENTITY: LinkedIn

 

ACADEMIC PREPARATION

• Ph.D. Biotechnology (2004) spl. Cancer Genetics; Panjab University, Chandigarh
• M.Sc.   Life Sciences (1998) Pondicherry Central University, Pondicherry 
• B.Sc. Botany (1996); Madras University

ACADEMIC IDENTITIES: https://scholar.google.co.in/citations?user=XvpKkBYAAAAJ&hl=en

                                 https://www.researchgate.net/profile/Siddharth_Sharma14/stats

 

 

EXPERIENCE

• PROFESSOR: Department of Biotechnology | TIET | 2023 - to date | Research/ Admin. & Teaching
• ASSOCIATE PROFESSOR: Department of Biotechnology | TIET | 2017 -2023 | Research/ Admin. & Teaching
• ASSISTANT PROFESSOR Department of Biotechnology | TIET | 2011 -2017 | Research & Teaching
• APPLICATION SCIENTIST: in Flow Cytometry in Beckman Coulter | 2009 -2011 
• POSTDOCTORAL FELLOW | Department of Pathology, University of Miami Miller School of Medicine, USA | 2007-2009
• POST-DOCTORAL FELLOW |Centre for Proteomics and Genomic Research in the Institute of Infectious Diseases and Molecular Medicine, University of Cape Town | 2005-2006
• RESEARCH ASSOCIATE |Ranbaxy Laboratories Gurgaon, India
• RESEARCH ASSOCIATE (Scientist Grade II) | Department  of  Biotechnology, National  Institute  of  Pharmaceutical Education  and  Research (NIPER, Mohali- |2002-2004

 

Membership of national/International organization

1. Member of clinical cytometry society (USA)

 

Honors/Awards

1. Awarded Young Scientist Award from Panjab Academy of Sciences 2002

2. Was awarded with the “Best Research Paper” in the year 2019 for the paper titled “Functional genetic variants in pre-miR-146a and 196a2 genes are associated with risk of lung cancer in North Indians” by Thapar Institute of Engineering & Technology, Patiala

3. Awarded Performance Incentive Scheme for the year 2014 by Thapar Institute of Engineering & Technology, Patiala

4. Post-Doctoral fellowship award by Procognia Ltd (2005-2006)

5. Post-Doctoral fellowship award by Miller school of Medicine, (2007-2009)

 

RESEARCH ACCOMPLISHMENTS

• SPONSORED RESEARCH PROJECTS COMPLETED:  60 lac INR (till date)
• Leading an independent research group in the area of Molecular Epidemiology/ Biomarker discovery/ Risk assessment
• Scientific contribution includes >84 peer-reviewed international publications| 10 Book chapters|
• Several Invited presentations in Seminars/ Conference / Refresher Courses and Webinars
• Research guidance & supervision:
  • Doctoral Thesis: Awarded-09|  | Ongoing -05
  • Graduate Dissertations: Awarded- 44| Ongoing- 02

 

ADMINISTRATION-OUTREACH

• Industry Associated Project (IAP) Coordinator| B.Tech. Biotechnology, TIET | 2023-
• MEMBER |Board of Studies (UG &PG)- Biotech Department |TIET| 2017-
• MEMBER |Board of Studies (UG & PG)- Biotech Department |GGDSD College, Chandigarh| 2022-
• MEMBER| Research Advisory Council (RAC), GGDSD College, Chandigarh |2022
• MEMBER |Senate-TIET | Thapar Institute of Engineering & Technology | 2013- to date
• PG COORDINATOR| Department of Biotechnology | TIET| 2018-2023
• TIME-TABLE COORDINATOR | Department of Biotechnology | TIET| 2013-2018
• PLACEMENT-COORDINATOR| Department of Biotechnology | TIET| 2018- to date
• MEMBER ETHICS COMMITTEE| Thapar Institute of Engineering & Technology | 2020- to date
• STUDENT COUNSELLOR| Department of Biotechnology| Thapar Institute of Engineering & Technology 2014-2023
• MEMBER editorial board of Journal Biotechnia
• MEMBER committee M.tech/MSc/ PhD admissions

EXPERT REVIEWER FOR REPUTED JOURNALS

Discovery Oncology| Scientific Reports | World Surgical Oncology | Genetic & Molecular Testing |     Future Oncology | Pharmacogenomics | Journal Cancer Management and Research | OncoTargets and Therapy | Cancer Biotherapy and Radiopharmaceuticals | Archives of Medical Research |Journal of Clinical Laboratory Analysis | BMC Cancer | Heliyon| Gene Reports | Disease Markers | Future Oncology |Cancer Genetics |Pulmonary Pharmacology

ORGANIZATION OF SYMPOSIA/CONFERENCES/SEMINARS

• Co-Convener | 2018 | International Conference on Drug Discovery: Biotech and Pharma at Crossroads, 15-17th Feb 2018| TIET 
• Co-Coordinator | 2017| Summer Training Program “Advances in Modern Biotechnology”, 05th June-12th July 2017 | TIET         
• Co-Coordinator | 2014 | Summer Training Program “Modern Biotechnology”, 09th June-15th July 2014 | TIET
•  Faculty Co-ordinator Summer Training in Industrial Biotechnology (June 02 – July 11, 2014) conducted by STEP, Thapar University
• Faculty Co-ordinator Summer Training in Industrial Biotechnology (June 03 – July 12, 2013) conducted by STEP, Thapar University
•  

ACADEMICS & TEACHING (+13 yrs) 

Courses taught”

UG (B.Tech. Biotech Program): Animal Biotechnology (UBT601) | STEM CELL TECHNOLOGY (UBT607) | Medical Biotechnology (UBT609) | CANCER BIOLOGY & INFECTIOUS DISEASE (UBT836) | Developmental Biology (UBT006) | CELL &TISSUE ENGINEERING (UBT513) |

PG (M.Sc./ M.Tech. Program): Animal & Stem Cell Technology (PBT306) Industrial Medical Biotechnology (PBT314) | Stem Cell & Tissue Engineering (PBY 302) | Transgenic Technologies (PBY214) |Diagnostic & Medical Microbiology (PMY304) | Molecular Medicine & Diagnostics (PBT 313)

• Coordinated & Developed | M.Tech. Biotech Program| Started in July 2012 |TIET

 

Publications list

Total Research papers=84

TIF=260

AVG TIF=3.09

 

2024

 

1. Heena Kansal, Vishal Chopra, Kranti Garg, Siddharth Sharma. (2024). Genetic variations in the antioxidant genes and their role in modulating susceptibility towards chronic obstructive pulmonary disease in the North Indian population. Free Radical Biology and Medicine 223:118-130 (IF=7.
2. S., Singh, N., Gupta, P. S., Panda, S. K., Dhamija, I., Nathiya, D., Kumar, S., & Sharma, S. (2024). Assessing the impact of MSH3 and MSH6 polymorphisms on lung cancer risk in North Indian patients undergoing platinum chemotherapy through molecular dynamics simulation. Scientific Reports, 14(1), 1-14. (IF=3.8)
3. Divyanshu Aggarwal, Siddharth Sharma, Manoj Gupta. (2024). Porous Mg-Hydroxyapatite composite incorporated with Aloe Barbadensis miller for scaphoid fracture fixation: A natural drug-loaded orthopaedic implant. Applied Sciences. IF=2.8
4. Bhatia A, Upadhyay AK, Sharma S. Screening and analysis of single nucleotide polymorphism in the 3'-UTR microRNA target regions and its implications for lung tumorigenesis. Pharmacogenomics. 2024 May 30:1-16. doi: 10.1080/14622416.2024.2355864. Epub ahead of print. PMID: 38884942. (IF=2.1)

 

2023

5. Heena Kansal, Kranti Garg, Vishal Chopra, Siddharth Sharma. (2023) Role of Thioredoxin in Chronic Obstructive Pulmonary Disease (COPD): A promising future target. Respiratory Research (In press) Impact factor=5.6
6. Singh, S., Singh, N., Baranwal, M. et al. Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy. 3-Biotech 13, 411 (2023). kjhttps://doi.org/10.1007/s13205-023-03826-2 (IF=2.8)
7. Harsh Yadav, Depanshi Pandit,  Sidhartha Singh,  Parul Sharma,  Kranti Garg,  Nidhi Girdhar,  Karan Sharma,  Vishal Chopra,  Siddharth Chopra,  Siddharth Sharma (2023). GST polymorphism as a predictive biomarker for modulating the susceptibility to chronic obstructive pulmonary disease: A North Indian study. Experimental Physiology. https://doi.org/10.1113/EP091339. IF=2.9
8. Siddharth Sharma Sidhartha Singh, Anu Gupta, Navneet Singh, Parth Sarthi Sengupta, Saroj Kumar Panda, and Siddharth Sharma. (2023). Genotyping, in silico screening and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients treated with platinum-based doublet chemotherapy. Journal of biomolecular structure and dynamics doi.org/10.1080/07391102.2023.2261052. (IF=4.4)
9. Jyothish K, Jawahar Lal Joshi, Heena Kansal, Vishal Chopra, Kranti Garg, Nidhi Girdhar, Karan Sharma, Rishabh Deshwal, Siddharth Sharma. (2023). Association of IL4RA and IL-8 polymorphism in predicting susceptibility towards tuberculosis. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2023.2594 (IF=1.
10. Depanshi Pandit, Parul Sharma, Harsh Yadav, Kranti Garg, Vishal Chopra, Siddharth Sharma. (2023). Association of IL4RA polymorphism in predicting susceptibility towards chronic obstructive pulmonary disease. Pharmacogenomics (Accepted)
11.  Abhishek Choudhary, Adarsh Anand, Amrita Singh, Pratima Roy, Navneet Singh, Vinay Kumar, Siddharth Sharma & Manoj Baranwal. (2023). Machine learning-based ensemble approach in prediction of Lung cancer predisposition using XRCC1 gene polymorphism. JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS. doi.org/10.1080/07391102.2023.2242492(IF=4.4)
12. Divyanshu Agarwal, SK Singla, Siddharth Sharma. (2023). Effect of rare earth oxide microparticles on mechanical, corrosion, antibacterial, and hemolytic behaviour of Mg-Hydroxyapatite composite for orthopedic applications- a preliminary in-vitro study. Journal of Biomedical Materials Research: Part B - Applied Biomaterials. 111(6) 1232-1246.  IF=3.405
13. Aggarwal, Divyanshu, Kumar, Vinod and Sharma, Siddharth. (2023). Development of Mg-based metal matrix biomedical composites for acicular cruciate ligament fixation by reinforcing with rare earth oxide and hydroxyapatite – A mechanical, corrosion, and microstructural perspective.. Science and Engineering of Composite Materials 30(1) 20220179https://doi.org/10.1515/secm-2022-0179 (De Gruyter, I.F= 1.9)

 

2022

14. Parul Sharma, Navneet Singh Siddharth Sharma. (2022). Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of Biochemical and Molecular Toxicology. 37(3):  e23269. Impact factor=3.568
15. Parul Sharma, Navneet Singh Siddharth Sharma. (2022). Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of Gene Medicine. 2022; 25 (1): e3460. Doi.org/10.1002/jgm.3460  Impact factor=4.152
16. Harleen Kaur Walia, Parul Sharma, Navneet Singh, Siddharth Sharma. (2022). Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians. International Journal of Environmental Health Research. 17;1-24. (DOI:10.1080/09603123.2022.2133095 in press) Impact factor=4.47
17. Divyanshu Agarwal, Siddharth Sharma, SK Singla. (2022). Investigation of the mechanical and corrosion properties of Mg-Hydroxyapatite composite by addition of rare-earth oxide particulates for biomedical applications. Journal of Mechanical Engineering Science. (237(2):420-439. Impact Factor=1.71      
18. Sidhartha singh, Navneet Singh, Siddharth Sharma (2022). Genetic polymorphisms in the mismatch repair pathway (MMR) genes contribute to hematological and gastrointestinal toxicity in North Indian lung cancer patients treated with platinum‐based chemotherapy. Journal of Biochemical & Molecular Toxicology. 36 (11): e23183 https://doi.org/10.1002/jbt.23183. Impact Factor=3.568      
19. Parul Sharma, Navneet Singh Siddharth Sharma. (2022). Polymorphisms in Solute carrier genes (SLC19A1, SLCO1B1, and SLCO1B3) predicts survival and toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of Clinical Pharmacy and Therapeutics 47(12): 2049-2067  https://doi.org/10.1111/jcpt.13748. Impact Factor=2.15
20. Sidharths singh, Manoj Baranwal, Navneet Singh, Siddharth Sharma (2022). Structural, functional analysis and association of MSH6 rs1800932, rs1042821 polymorphisms with clinical outcome in North Indian lung cancer patients treated with platinum-based doublet chemotherapy. The American Journal of the Medical Sciences. 364(6):735-745  https://doi.org/10.1016/j.amjms.2022.07.005. Impact Factor=3.4
21. Anmol Bhatia, Atul Kumar Upadhyay, Siddharth Sharma. (2022).  miRNAs are now starring in "No Time to Die: overcoming the chemoresistance in cancer. IUBMB LIFE. 75(3):238-256. DOI: 10.1002/iub.2652 2022. Impact Factor= 4.7
22. Harleen Kaur Walia Parul Sharma, Navneet Singh, Siddharth Sharma. (20. Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy. Xenobiotica. 52(3): 322-331.Impact Factor=1.99
23. Parul Sharma, Siddharth Sharma. (2022). In silico screening and analysis of single-nucleotide polymorphic variants of the ABCC2 gene affecting Dubin–Johnson syndrome. Arab Journal of Gastroenterology.23(3) 172-187 https://doi.org/10.1016/j.ajg.2022.03.003. Impact Factor=1.8
24. Divyanshu Agarwal, SK Singla, Siddharth Sharma. (2022). Drug-Loaded Biomaterials for Orthopedic Applications: A Review. Journal of Controlled Release. 344:113-133. Impact Factor=11.46
25. Shweta Lawanai, Sidhartha Singh, Navneet Singh, Digambar Behera, Siddharth Sharma. (2023). Single Nucleotide Polymorphisms of nucleotide excision repair genes and their association with overall survival in North Indian lung cancer patients treated with platinum-based doublet chemotherapy. Journal of Cancer research & Therapeutics. 19(2):408-419. Impact Factor=1.33
26. Parul Sharma, Navneet Singh, Siddharth Sharma. (2022). Polymorphism in Thymidylate synthase gene predicts survival and toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy         Oncology. ISSN: 0030-2414 1423-0232 (Online) (DOI:10.1159/000522204) Impact Factor=3.73
27. Harleen Walia, Parul Sharma, Navneet Singh, Siddharth Sharma (2022). Immunotherapy in small cell lung cancer treatment: A promising headway for future perspective. Current treatment options in oncology. 23:268–294. Impact Factor=5.08                                  
28. Nidhi Girdhar, Heena Kansal, Kranti Garg, Siddharth Sharma, K. Sandeep Prabhu, Vishal Chopra, Alexey A. Tinkov, Anatoly V. Skalny, N. Tejo Prakash. (2022). Correlation of serum selenium in asthma patients with severity of the disorder. Biological Trace Element Research. 200(12):4949-4954. https://doi.org/10.1007/s12011-022-03096-8. Impact Factor=4.08

 

2021

29. Sidhartha Singh, Siddharth Sharma, Manoj Baranwal. (2021). Identification of SNPs in hMSH3/MSH6 interaction domain affecting the structure and function of MSH2 protein        . Biotechnology and Applied Biochemistry.  69(6):2454-2465. DOI: 10.1002/bab.2295. Impact Factor=2.72
30. Harleen Kaur Walia, Navneet Singh, Siddharth Sharma. (2021)       Association of NAT-2 gene polymorphisms towards lung cancer susceptibility and prognosis in North Indians. Pharmacogenomics. 23 (2): 97-118. Impact Factor=2.63
31. Sidharths singh, Manoj Baranwal, Navneet Singh, Siddharth Sharma. (2021) Polymorphisms in the MSH2 gene predict poor survival of North Indian lung cancer patients undergoing chemotherapy Biomarkers in Medicine 16(2):69-82. Impact Factor=2.5
32. Harleen Kaur Walia, Navneet Singh, Siddharth Sharma. (2021) GSTP1 Ile105Val polymorphism among North Indian lung cancer patients treated using monotherapy and poly-pharmacy. Human and Experimental Toxicology. 40(12S): S739–S752. Impact Factor=3.247
33. Harleen Kaur Walia, Navneet Singh, Siddharth Sharma. (2021)       MTHFR polymorphism as a predictive biomarker for Gastrointestinal and Hematological toxicity in North Indian adenocarcinoma patients after treatment with pemetrexed and platinum-based doublet chemotherapy. Journal of Chemotherapy. 34(5) 326-340. Impact Factor=2.385
34. Parul Sharma, Navneet Singh, Siddharth Sharma. (2021).  ATP binding cassette (ABC) transporters and cancer: Revisiting the controversial role. Pharmacogenomics. 22(18):1211-1235         Impact Factor=2.63
35. Sidhartha Singh, Navneet Singh, Manoj Baranwal, Siddharth Sharma. (2021). Association of MLH1 -93G>A polymorphisms towards lung cancer susceptibility and its association with clinical outcome in North Indian patients treated with platinum-based chemotherapy. Journal of Cancer research & Therapeutics. Print -0973-1482, Online - 1998-4138. 10.4103/jcrt.jcrt_465_21 Impact Factor=1.33
36. Harleen Kaur Walia, Navneet Singh, Siddharth Sharma. (2021). Genetic Polymorphisms in the microsomal Epoxide Hydrolase (mEH) gene in relation to tobacco smoking: role in lung cancer susceptibility and survival in North Indian Lung cancer patients undergoing platinum-based chemotherapy.        Future Oncology. 17(35): 4925-4946. Impact Factor=3.674
37. Harleen Kaur Walia, Navneet Singh, Siddharth Sharma. (2021). Genetic polymorphism of Arg213His variant in the SULT1A1 gene is associated with reduced susceptibility to lung cancer in North Indian population. Xenobiotica. 51,(9):1071–1080. Impact Factor=1.99
38. Harleen Kaur Walia, Navneet Singh, Siddharth Sharma. (2021). NQO1 polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. Personalized Medicine. 18(4):333-343. Impact Factor=2.12
39. Ankan Bandyopadhyay, Siddharth Sharma, Digambar Behera, Navneet singh. (2021). UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan‐Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall survival. The Oncologist. 26(8):701-713. Impact Factor=5.837

 

2020

40. Anand Manju, Sharma Siddharth, Monga Preetika.(2020). Antimicrobial and antioxidant potential of Tylophora indica (Burm. f.) Merrill and development of an efficient micropropagation system for its therapeutic use Medicinal Plants - International Journal of Phytomedicines and Related Industries. 12(1):82-89.

 

2019

41. Harleen Kaur Walia, Ushina Verma, Navneet Singh, Siddharth Sharma. (2019). Polymorphisms in GSTM1 and GSTT1 influence response and treatment outcome in lung cancer patients treated with platinum-based chemotherapy.        British Journal of Biomedical Science. 76(4):198-200. Impact Factor=3.829
42. Shweta Lawania, Navneet Singh, Digambar Behera & Siddharth Sharma. (2019).         XPG polymorphisms and their association with lung cancer susceptibility, overall survival and response in North Indian Patients treated with platinum-based doublet chemotherapy. Future oncology. 15(2):151-165 Impact Factor=3.674
43. Amrita singh, Navneet Singh, Digambar Behera & Siddharth Sharma. (2019). XRCC1 632 as a candidate for cancer predisposition via a complex interaction with genetic variants of base excision repair and double strand break repair genes. Future Oncology. 15(33):3845-3859 doi10.2217/fon-2019-0297. Impact Factor=3.674
44. Shweta Lawania, Amrita singh, Navneet Singh, Digambar Behera & Siddharth Sharma. (2019). The multi-faceted high order polymorphic synergistic interactions among nucleotide excision repair genes increase the risk of lung cancer in North Indians. Mutat Res Fund Mol Mech Mutagen. https://doi.org/10.1016/j.mrfmmm.2019.111673. 816-818:111673. Impact Factor=3.151
45. Noorpreet I. Dhanjal, Siddharth Sharma, et al. (2019). Selenium-rich maize modulates the expression of prostaglandin genes in lipopolysaccharide stimulated RAW264.7 macrophages. Food and Function. 10: 2839-2846. Impact Factor=6.317
46. S. Singh, R.S. Kaler and S. Sharma. (2019). FEM simulation analysis of fiber optic surface plasmon resonance sensor based on array of circular gold nanorod. Optik. 183:508-512. Impact Factor=2.84
47. S. Singh, R.S. Kaler and S. Sharma. (2019). Resonance Effect of Bimetallic Diffraction Grating on the Sensing Characteristics of Surface Plasmon Resonance Sensor with COMSOL Multiphysics. Journal of Nanoelectronics and Optoelectronics. 14(5): 669–674. Impact Factor =0.697

 

2018

48. S. Singh, R.S. Kaler and S. Sharma. (2018). A Novel Two-Dimensional Material Based Optical Fiber Surface Plasmon Resonance Sensor for Sensing of Organic Compounds in Infrared Spectrum Window. Journal of Communications Technology and Electronics. 63: 1269-1275. Impact Factor= 0.529
49. Charu Bahl, Navneet Singh, Digambar Behera, Navneet Singh, Digambar Behera & Siddharth Sharma. (2018). Genetic variants in Wnt antagonist genes predicts the overall survival and prognosis of North Indian lung cancer patients treated with platinum based doublet chemotherapy. Cancer Biotherapy and Radiopharmaceuticals. 33 (10): 466-477. Impact Factor=3.632
50. Shweta Lawania, Navneet Singh, Digambar Behera & Siddharth Sharma. (2018).         Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North Indians. Biochemical Genetics. 56 (4):375-396. Impact Factor=2.22
51. Amrita Singh, Navneet Singh, Digambar Behera & Siddharth Sharma. (2018). Role of polymorphic XRCC6 (Ku70/ XRCC7 (DNAPKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy. Molecular Biology Reports. 45(3): 253-261 Impact Factor= 2.742
52. Shweta Lawania, Navneet Singh, Digambar Behera & Siddharth Sharma. (2018). XPF polymorphism toward lung cancer susceptibility and survival in patients treated with platinum-based chemotherapy. Future Oncology. 14(11): 1071-1089. Impact Factor= 3.674
53. Apurva Bhardawaj, Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2018). Interactive potential of genetic polymorphism in Xenobiotic metabolizing and DNA repair genes for predicting lung cancer predisposition and overall survival in North Indians. Mutation Research and Genetic Toxicology.  826: 15-24. Impact Factor=2.873
54. Amrita Singh, Navneet Singh, Digambar Behera,  Siddharth Sharma. (2018). Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy. Pathology & Oncology Research. 25: 1327–1340. Impact Factor=2.874
55. Sneha, Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2018).  Role of sequence variations in AhR gene towards modulating smoking induced lung cancer susceptibility and Clinical outcomes in North Indian population: A multiple interaction analysis. Current Genomics.19: 313-326 Impact Factor=2.689

 

2017

56. Vijay Kumar Bodal, Shruti Sangwan , Manjit Singh Bal , Mohanvir Kaur , Siddharth Sharma, Bhavleen Kaur. (2017).    Association between Microrna 146a and Microrna 196a2 Genes Polymorphism and Breast Cancer Risk in North Indian Women. Asian Pacific Journal of Cancer Prevention. 18:2345-2348. Impact Factor=2.52
57. Ankita Pandey, Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2017). Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients. Tumori. 104(3): 179-187. Impact Factor= 2.438
58. Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2017). High order gene interactions between the genetic polymorphisms in Wnt and AhR pathway towards lung cancer susceptibility. Personalized Medicine. 14(6): 487-502. Impact Factor=2.12
59. Noorpreet Dhanjal, Siddharth Sharma, Suresh Prabhu, N Tejo Prakash. (2017). Selenium supplementation through Se-rich dietary matrices can upregulate the anti-inflammatory responses in lipopolysaccharide-stimulated murine macrophages. Food and Agricultural Immunology. 28 (6): 1374-1392. Impact Factor=3.268
60. Shweta Lawania, Navneet Singh, Digambar Behera & Siddharth Sharma. (2017). XPD polymorphism towards lung cancer susceptibility survival and response in patients treated with platinum chemotherapy.       Future Oncology. 13(22): 1945–1965. Impact Factor=3.674
61. Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2017). Single Nucleotide Variations in the Wnt antagonist sFRP3 (rs7775 & rs288326) and sFRP4 (rs1802073 &1802074) genes and their association with lung cancer risk in North Indians. Meta Gene. 13: 159-168.
62. Shweta Lawania, Navneet Singh, Digamba rBehera & Siddharth Sharma.       (2017). XPC Polymorphism and risk for lung cancer in North Indian patients treated with platinum based chemotherapy and its association with clinical outcomes. Pathology & Oncology Research. 24(2): 353-366 Impact Factor=2.87
63. Amrita Singh, Navneet Singh, Digambar Behera & Siddharth Sharma. (2017). Polymorphism in XRCC1 gene modulates survival and clinical outcomes of Advanced North Indian Lung cancer patients treated with platinum based doublet chemotherapy. Medical Oncology. 34 (4): 64-78. Impact Factor=3.738
64. Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2017). Association of candidate genetic variations in Axin2 gene with lung cancer risk in North Indian population: A multiple-interaction analysis. Tumor Biology. 39: 1:18. Impact Factor=3.65

 

2016

65. Amrita Singh, Navneet Singh, Digambar Behera & Siddharth Sharma. (2016). Association and multiple interaction analysis among five XRCC1 polymorphic variants in modulating lung cancer risk in North Indian population. DNA Repair. 47: 30–41. Impact Factor=4.354
66. Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2016). Association of polymorphisms in Dickopff (DKK) gene towards modulating risk for lung cancer in north Indians. Future Oncology. 13 (3): 213-232. Impact Factor=3.674
67. Ankita Kumar, Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2016). Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy. Molecular Biology Reports. 43: 1383–1394. Impact Factor=2.742
68. Yashila Girdhar, Navneet Singh, Digambar Behera & Siddharth Sharma. (2016). Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers. Int J Biol Markers. 31(4):e402-e412. Impact Factor=3.248
69. Girdhar Y, Singh N, Behera D, Siddharth Sharma. (2016). Combinations of the variant genotypes of CYP1A1, GSTM1 and GSTT1 are associated with an increased lung cancer risk in North Indian population: a case-control study. Pathology & Oncology Research. 22(3): 647-652. Impact Factor=2.87

 

2015

70. Sharma N, Singh A, Singh N, Behera D, Siddharth Sharma. (2015). Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population. Cancer Epidemiology. 39(6): 947-955.  Impact Factor=2.89
71. Sodhi KK, Bahl C, Singh N, Behera D, Siddharth Sharma. (2015). Functional Genetic Variants in pre-miR-146a and 196a2 genes are associated with risk of lung cancer in North Indians. Future Oncology. (15):2159-2173. Impact Factor=3.674

 

2016

72. Noorpreet I. Dhanjal, Siddharth Sharma, and N. Tejo Prakash. (2016). Quantification and In Vitro Bioaccessibility of Selenium from Osborne Fractions of Selenium-Rich Cereal Grains. Cereal Chemistry. 93 (4): 339-343. Impact Factor=2.534
73. Saronika Jindal, Shruti Sobti; Mukesh Kumar; Siddharth Sharma; Manoj Kumar Pal. (2016) Nanocavity-Coupled Photonic Crystal Waveguide as Highly Sensitive Platform for Cancer Detection. IEEE Sensors Journal. (10): 3705-3710. Impact Factor=4.325

 

2010

74. Siddharth Sharma, Shariatmadar Sherry;  Krishan Awtar. (2010). Electronic Volume, Aldehyde dehydrogenase and Stem Cell Marker Expression in Cells from Human Peripheral Blood Apheresis Samples. Cytometry B (Clinical Cytometry). 78B:123-129. Impact Factor=3.248
75. Krishan Awtar, Deepti Sharma, Siddharth Sharma, (2010). ALDH+/CD44+/CD24- Expression in Cells from Body Cavity Fluids.  Clinical Cytometry (Cytometry B). 78B: 176-182. Impact Factor=3.248

 

2008

76. Siddharth Sharma; Cabana Raquel , Shariatmadar Sherry;  Krishan Awtar. (2008).  Cellular volume and marker expression in human peripheral blood apheresis stem cells.           Cytometry Part A. 73 (2): 160-167. Impact Factor=4.714
77. Shariatmadar Sherry;  Siddharth Sharma. (2008). Electronic volume of CD34 positive cells from peripheral blood apheresis samples. Cytometry. Part B, Clinical Cytometry. 74 (3): 182-188 Impact Factor=3.248

 

2005

78. S. Agarwal*, S. Sharma*, V. Agarwal and N. Roy*(2005).        Caloric Restriction Augments ROS Defense in S. cerevisiae, by a Sir2p Independent Mechanism. Free Radical Research. 39:55-62. Impact Factor=4.354
79. R.C. Sobti,*, A.I. Al-Badran, S. Sharma, S.K. Sharma, A. Krishan, H. Mohan. (2005).  Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genetics and Cytogenetics. 156: 68–73. Impact Factor=2.169

 

2004

80. Sobti, R.C, Sharma, S, Jindal; 5K., and Janmeja; A. (2004). Genetic polymorphism of the CYP1A1, CYP2ET, GSTMI and GSTTI genes and lung cancer susceptibility in North Indian population. Molecular & Cellular Biochemistry            . 266: 1-9. Impact Factor=3.842

2003

81. Sobti, R.C, Sharma, S, Joshi, A., .Jindal, S.K., Janmeja, A. (2003). CYPIAI and CYP2D6 polymorphism and risk towards lung cancer in a North Indian population. Biomarkers. 8(5): 415-428. Impact Factor=2.66
82. Gill, T., Sharma, V., Mamtesh, Sharma, S., Sobti, R.C. (2003). RAPD-PCR analysis in two species of Catopsilia. Carologia. 56: 100-105. Impact Factor=1.47

2001

83. RC Sobti, S Sharma (2001). Molecular genetics of cancer with special reference to cancers of GI tract, Lung, Head and Neck and Cervix. JPAS. 1: 63-67.

2000

84. RC Sobti, S Sharma (2000). Molecular markers in lung cancer. Nucleus. 43(1,2): 71-82.         

 

BOOK CHAPTERS (INTERNATIONAL):

1. Siddharth Sharma and RC Sobti. Deciphering the role of immune-checkpoint inhibitors in lung cancer treatment. Molecular Biomarkers for Cancer Diagnosis and Therapy 2023.

 

2. Siddharth Sharma and RC Sobti Molecular pathogenesis of lung cancer: evolving landscape based on experience Molecular Biomarkers for Cancer Diagnosis and Therapy 2023.

 

3. Siddharth Sharma and RC Sobti The evolution of cancer research from genetics to omics. Evolution and development of emerging of technologies 2023

 

4. Siddharth Sharma and Awtar Krishan. Electronic Volume of Hematopoietic Stem Cells. In:Flow Cytometry Applications in Stem Cell Research, Eds. Awtar Krishan, H Krishnamurthy and Satish Totey, John Wiley-Blackwell Publications; 2010.

 

5. Molecular genetics of Gastrointestinal Tract Cancers. (2002). In book:Some aspects of Chromosome Structure and Function. Pp 177-1 92 (Eds) Sobti, R.C. eta!. Publishers (Kluwer & Narosa).

 

6. Telomere Telomerase and Cancer. (2002), In book: Some aspects of Chromosome Structure and Function. pp 168-191 (Eds) Sobti, R.C. et at Publishers (Kluwer & Narosa).

 

 

 

 

 4. Tumor Inflammatory Microenvironment in Lung Cancer: Heterogeneity and Implications https://link.springer.com/referenceworkentry/10.1007/978-981-99-2196-6_20-1
 

   

5. The Evolution of Cancer Research from Genetics to Omics

https://www.cambridgescholars.com/product/978-1-4438-5758-1
 

 6.     Milestones in Cancer Research

https://www.sciencedirect.com/science/article/abs/pii/B9780323951166000086

 

Research collaborations:

• Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh
• Department of Pulmonary Medicine, Government Medical College, Patiala
• Department of Pathology, Rajendra Medical College, Patiala

 

     PhD and Post-Graduate students (from all sources) working with the mentor.

Thesis supervision	Completed	Ongoing	Thesis submitted
PhD	9	5
DM	1
MD	3
M.Tech	14	2
M.Sc	28	--

 

 

 

 

 

 

 

 

DOCTORAL SUPERVISION (DETAILS)

AWARDED

Parul Sharma, PhD in Biotechnology, 2023| Thesis title: SNP analysis in ATP-binding cassette, Solute carrier transporters and Thymidylate synthase genes in North Indian lung cancer patients |Presently: Assistant Professor in Chandigarh University

Sidhartha Singh, PhD in Biotechnology, 2022| Thesis title: Single nucleotide polymorphism in mismatch repair pathway genes and its computational analysis in lung Cancer patients |Presently: Assistant Professor at DY Patil University, Pune

Harleen Kaur Walia Singh, PhD in Biotechnology, 2022| Thesis title: The role of Phase II detoxification genes towards modulating risk for lung cancer and its association with clinical outcomes |Presently: Research Associate at IIT Mumbai

Charu Bahl, PhD in Biotechnology, 2020| Thesis title: Study of the Genetic polymorphisms and Methylation profile in the Wnt signaling pathway with risk of occurrence of Lung| Presently: Scientific Officer at Medgenome, Delhi

Sarabjit Singh, PhD in Biotechnology, 2020| Thesis title Investigation of fibre optic sensor based on surface plasmon resonance for sensing applications |Presently: Assistant Professor, ECE Department, Chandigarh University

Shweta Lawania, PhD in Biotechnology, 2019| Thesis title: Studies on genetic polymorphism in nucleotide excision repair genes in relation to lung cancer patients |Presently: Assistant Professor at Devbhoomi Uttarakhand University. Bundelkhand

Amrita Singh, PhD in Biotechnology, 2019| Thesis title: Single Nucleotide Polymorphisms in the Base Excision Repair and Double Strand Break Repair pathway genes in Lung Cancer patients and their correlation with clinical outcomes |Presently: assistant professor at NIT Rourkela

Noorpreet Dhanjal, PhD in Biotechnology, 2018| Thesis title: Anti-inflammatory responses of bioavailable selenium from selenium-rich cereal grains |Presently Surrey Memorial Hospital

Ankan Banerjee, DM in Pulmonary Medicine, 2016| Thesis title: UGT1A1 polymorphism in small cell lung cancer patients undergoing irinotecan-based chemotherapy and its association with clinical outcome |Presently: Pulmonologist at Woodlands Hospital, Kolkata

 

ONGOING PhD Thesis

Heena Kansal, Ph.D. in Biotechnology |Thesis title: Genetic Variants in Lung function and Airway remodelling genes towards modulating the risk for development of chronic obstructive pulmonary disease(COPD)

Anmol Bhatia, Ph.D. in Biotechnology |Thesis title: Single Nucleotide Polymorphism in microRNA genes and its association with lung disorders

Nidhi Mahajan, Ph.D. in Biotechnology |Thesis title: Polymorphic Variants in the Sonic Hedge Hog and Transforming Growth Factor-β Signaling pathway-related Genes in Chronic Obstructive Pulmonary Disease

Ankita Goyal, Ph.D. in Biotechnology |Thesis title: Elucidating the role of genetic variants in the PI3K/AKT/mTOR pathway and its implications for the pathogenesis of Chronic Obstructive Pulmonary Disease

Pratima ROY, Ph.D. in Biotechnology |Thesis title: Identification of Functional SNPs in Interleukin-4 gene and it's association with Chronic Obstructive Pulmonary Disease.

 

M. Tech/MD Thesis

S. No.	Title of the thesis	Level M.Tech./ MD	Year	Supervisor/ Co-supervisor	Completed/ ongoing
1	Identification and characterization of functional single nucleotide polymorphisms (SNPs) in the destruction complex of Wnt signalling pathway involved in lung carcinogenesis: A computational approach	M.Tech	2021	Supervisor	Completed
2	Quality Assurance and Regulatory process for Orthopedics	M.Tech	2020	Supervisor	Completed
3	Prognostic significance of MGMT & ERCC1 gene polymorphism in lung cancer patients treated with platinum-based doublet chemotherapy	M.Tech	2018	Supervisor	Completed
4	Role of TGF-β and Wnt antagonist gene sFRP4 in predicting overall survival and clinic-pathological outcomes in lung cancer patients treated with platinum based doublet chemotherapy	M.Tech	2017	Supervisor	Completed
5	Search for Novel SNPs in XPC, XPD and XPG Genes	M.tech	2016	Co-Supervisor	Completed
6	Phytochemical Studies and Evaluation of Antimicrobial Potential of native and micropropagated plants of Tylophora Indica : A comparative study	M.tech	2016	Supervisor	Completed
7	Aryl hydrocarbon Receptor gene polymorphism and its association towards Lung Cancer risk and Clinical outcomes	M.tech	2016	Supervisor	Completed
8	Prognostic role of p53 codon 72 polymorphism in North Indian Lung cancer pateints treated with platinum based chemotherapy	M.tech	2016	Supervisor	Completed
9	Synergistic association of CYP1A1 and CHRNA5 D398N genetic variants towards increased susceptibility for Lung Cancer in North Indian Population	M.tech	2015	Supervisor	Completed
10	Functional role of ccnd1 gene polymorphism (g870a) in modifying susceptibility towards lung cancer risk and overall survival of lung cancer patients	M.tech	2015	Supervisor	Completed
11	Evaluation Of SNP’s In The Phase I (CYP1A1) And Phase II (GSTM1 &GSTT1 &GSTP1) Detoxification       Genes With Risk For Occurrence of SCLC And NSCLC	M.tech	2014	Supervisor	Completed
12	Association of Single Nucleotide  Polymorphism  in microRNA 146a and196a2, and  it’s impact on  lung cancer in North Indian Population	M.tech	2014	Supervisor	Completed
13	Assessment of serum levels of selenium and the role of il-4/il4ra polymorphism in patients of asthma and its correlation with severity of asthma	MD	2020	Co-Supervisor	Completed

 

 

 

                   MSc Thesis

S. No.	Title of the thesis	Year	Supervisor/ Co-supervisor	Completed
1	Identification of functional Single Nucleotide Polymorphisms (SNPs) in Superoxide Dismutase 3 (SOD3) gene and its association with Chronic Obstructive Pulmonary Disease (COPD)	2021	Supervisor	Completed
2	Decoding the significance of toll-like receptor (TLR) signaling in cerebral malaria pathology	2021	Co-Supervisor	Completed
3	Polymorphisms in the IL4, IL4Ra genes and its synergistic association with selenium status in patients with asthma severity	2020	Supervisor	Completed
4	GSTP1 as a potential predictive factor for adverse events associated with platinum-based antitumor agent-induced toxicity	2020	Supervisor	Completed
5	In silico analysis of SNPs in ABCB1 gene affecting lung cancer associated protein P – glycoprotein (P-gp)	2020	Supervisor	Completed
6	Cloning, Overexpression and Purification of RNase D in Escherichia coli	2019	Co-Supervisor	Completed
7	Genetic Polymorphism of Thymidylate Synthase gene in Lung Cancer Patients Undergoing Platinum Based Chemotherapy	2019	Supervisor	Completed
8	Genetic Polymorphism in NQO1 gene and its Association with Lung Cancer  in North Indian Population	2018	Supervisor	Completed
9	Prognostic significance of ABCB1 (MDR-1) gene variants (C1236Tand G2677T) in lung cancer patients treated with  platinum-based doublet chemotherapy	2018	Supervisor	Completed
10	Role of DNMT3B genetic polymorphism (rs1569686) in predicting overall survival and clinic-pathological outcomes in lung cancer patients treated with platinum based doublet chemotherapy	2017	Supervisor	Completed
11	Predictive potential role of GSTT1 and GSTM1 genes in the overall survival and treatment outcome of lung cancer patients treated with platinum-based doublet chemotherapy	2017	Supervisor	Completed
12	Polymorphism in the UGT1A1 gene and its association with small cell lung cancer in North Indian population	2016	Supervisor	Completed
13	Evaluation of Antimicrobial and Antioxidant potential of native and micropropagated plants of Tylophora indica	2016	Co-Supervisor	Completed
14	Association of Aryl Hydrocarbon Receptor gene polymorphism with the risk of Lung Cancer in North Indian population	2014	Supervisor	Completed
15	Role of XRCC1 DNA repair gene polymorphisms (Arg399Gln and Arg194Trp) on outcome of Platinum based chemotherapy for Lung cancer in North Indian Population	2014	Supervisor	Completed
16	Association of micro RNA 196a2 and 146 polymorphism towards risk of breast cancer	2014	Supervisor	Completed
17	Association of single nucleotide polymorphism in microrna 196a2 and 146a gene towards risk for lung cancer in north indian population	2013	Supervisor	Completed
18	Association of rs2073498 ala133ser gene polymorphism with risk towards lung cancer susceptibility in a north indian population	2013	Supervisor	Completed
19	Case-control study of HER2/ neu Ile655Val single nucleotide polymorphism in relation towards risk for breast cancer	2013	Supervisor	Completed
20	Genetic variation in cyp1a1 gene towards risk of occurrence of lung carcinoma in north indian population	2013	Co-Supervisor	Completed
21	SNP genotyping of the reck gene in lung cancer	2013	Supervisor	Completed
22	Susceptibility od Foxp3 rs2294021 polymorphism in relation to breast cancer	2013	Supervisor	Completed
23	Cytotoxic potential of fungal extracts against a549 cell line and its potential in drug development	2013	Co-Supervisor	Completed

 

 

 

POSTER PRESENTATIONS/ORAL PRESENTATIONS/ABSTRACTS/FACULTY DEVELOPMENT

1. Participated as a faculty in the “3^rd Lung multidisciplinary cancer management course” organised by PGIMER, Chandigarh and American society of clinical oncology from 24-25^th March, 2018.
2. XPD polymorphism and its association with lung cancer risk, overall survival and response in north Indian patients treated with platinum--based chemotherapy. S. Lawania, S. Sharma, N. Singh, D. Behera. Poster presentation at 2nd Indian cancer congress 08 - 12 November, 2017 Bengaluru,
3. Role of Polymorphic Variants of BER and DSBR Pathway Genes in Modulating Lung Cancer Susceptibility and Prognosis of North Indian Population” A. Singh, S. Sharma, N. Singh, D. Behera. Presented at IASLC 18TH WORLD CONFERENCE ON LUNG CANCER, October 15-18, 2017, Yokohama, Japan.
4. UGT1A1 gene polymorphisms and clinical outcomes in small cell lung cancer (SCLC) patients treated with irinotecan-platinum chemotherapy: The first study from north India. Navneet Singh, Ankan Bandyopadhyay, Siddharth Sharma, Digambar Behera. Abstract presentation. 2017 American Association of clinical oncology (ASCO) Annual Meeting (June 2-6, 2017) Chicago, Illinois.
5. Genetic variants in the Wnt antagonist genes (sFRP, Dkk and Axin2) predicts the overall survival and prognosis of North Indian lung cancer patients treated with platinum-based doublet chemotherapy. Charu Bahl, Siddharth Sharma, Navneet Singh, Digambar Behera. Poster Presentation at CHASCON 2017 meeting9-11 March, 2017, Panjab University, Chandigarh
6. Participated in “Research and grant proposal workshop” organized by Monk Prayogshala 4^th May 2017
7. Participated in FDP “New directions in teaching and Learning 2016” organised by Trinity College Dublin and Thapar University
8. Participated and attended FDP “How to write a research proposal for funding” organized by Centre of training and development, Thapar University, May 4,2017
9. Participated and attended FDP “Class Room comminication” organized by Centre of training and development, Thapar University, May 2, 2017
10. Se-dietary matrices can upregulate the anti-inflammatory responses in RAW macrophages. Noorpreet Dhanjal Siddharth Sharma, Sandeep Prabhu Kumble, Tejo Prakash Nagaraja. Poster Presentation at 4th International Conference on Selenium in the Environment and Human Health. (18-21 October 2015, Sao Paulo, Brazil)
11. Synergistic association of CHRNA5 (rs16969968) polymorphism towards increased susceptibility to squamous Cell Lung Cancer in North Indian Smokers.. Oral Presentation at International Conference on Advances in Biomedical Engineering, cancer Biology, bioinformatics and applied biotechnology (ABECBAB) 25-26th July Yashila Girdhar, Siddharth Sharma, Navneet Singh, Digambar Behera 2015, JNU, New Delhi.
12. CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients. Ankita Pandey, Siddharth Sharma, Navneet Singh, Digambar Behera. Oral Presentation at International Conference on Advances in Biomedical Engineering, cancer Biology, bioinformatics and applied biotechnology (ABECBAB) 25-26th July 2015, JNU, New Delhi.
13. Participated as faculty in “National Seminar of Innovation and Entrepreneurship” organized by STEP, Thapar University 26^th April 2013
14. Participated as faculty in “National workshop on Natural vinegar and naturally carbonated beverage production” organized by STEP, Thapar University 31 October 2013
15. Stem cell marker expression in cells from body cavity fluids. Awtar Krishan, Deepati Sharma, Siddharth Sharma, Ronald Hamelik, Parvin Ganjei-Azar, and Mehrdad Nadji. Presented at 24th Annual Meeting of the Clinical Cytometry Society October 16–18, 2009, Jacksonville, Florida, USA.
16. Electronic Volume and ALDH expression in Stem cells from human Apheresis samples by Siddharth Sharma, Sherry Shariatmadar, Raquel Cabana, and Awtar Krishan. Presented at The 23rd Annual Meeting of the Clinical Cytometry Society October 12–14, 2008 Portland, Oregon, USA
17. Electronic Volume  of  Stem  Cells  in  Human  Apheresis  Samples  by  Siddharth Sharma, Raquel Cabana, Sherry Shariatmadar, Awtar Krishan. Presented at the ISAC XXIV International Congress, May 17-21, 2008 held at Budapest Hungary
18. Electronic Cell Volume and Marker Expression in Stem Cells from Human Apheresis Samples by Siddharth Sharma, Raquel Cabana, Sherry Shariatmadar, Awtar Krishan. Presented at the AACR at San Diego, CA, USA on April12-16 2008.
19. Electronic Volume  of  Hematopoietic  Stem  Cells  by  Siddharth  Sharma,  Raquel Cabana, Sherry Shariatmadar, Awtar Krishan. Presented at the 22nd Annual Clinical Cytometry society at Washington D.C. on October 16-19 2007.
20. “P450-BIOCHIPS by Siddharth Sharma Natasha Beeton and JM Blackburn. Presented at the international conference on “A Molecular Meander in the Midlands” organized by South African Society for Biochemistry and Molecular Biology at PeiterMaritzburg, South Africa, on July 3-56h, 2006.
21. Participated in “INDO-US workshop on advanced flow cytometry” from 18-22^nd February 2002, Panjab University, Chandigarh
22. Participated in symposium on “100years of post mendelian genetics: advent of biotechnology” 10-12 december, 2002, Panjab University, Chandigarh
23. Participated in “Sixth chandigarh symposium on new biology (Molecular Medicine) 19-20^th march, Panjab Univeristy, Chandigarh

 

INVITED LECTURE

• Guest lecture on “Flow cytometry and its role in modern biology” delivered to department of biotechnology GGDSD College, Chandigarh 11th of November 2017.
• Guest speaker on “Flow cytometry and its clinical applications” in 49th Annual Conference of Indian Pharmacological Society (IPSCON-2016), India Scheduled on 20th to 23rd October 2016.